Momentum Biotechnologies acquires OmicScouts
03/05/25, 1:35 PM
Location
billerica
freisingIndustry
biopharma
pharmaceutical
biotechnology
biotechnology
Momentum Biotechnologies has announced the successful acquisition of OmicScouts GmbH, enhancing its mass spectrometry-based services. This acquisition allows Momentum to expand its offerings and geographic reach into the European market. Both companies align in their technical foundations and client relationships, making the acquisition a strategic fit. OmicScouts will operate as a subsidiary of Momentum.
Company Info
Location
Billerica, Massachusetts, United States
Company info
Momentum Biotechnologies is a drug discovery partner providing specialized, cutting-edge mass spectrometry technologies to biopharmaceutical clients across the globe. They focus on mass spectrometry-based drug discovery and offer a variety of services to enhance drug development processes. The company is committed to scientific rigor and ongoing technological innovation.